fr
Article scientifique
Commentaire
Accès libre
Anglais

Cannabinoids and COVID-19

Date de publication2020
Résumé

Since the endocannabinoid system is involved in immune function, the effect of cannabinoid intake on infectious conditions is questioned for several years and is of particular interest in the COVID 19 pandemia. Some data suggest that the immunomodulatory effect of cannabinoids may affect the course and severity of SARS-CoV-2 infection. Given the large number of cannabinoids consumers in the community, this commentary presents the current knowledge on the potential impact of cannabinoids and endocannabinoids on bacterial and viral infection courses namely SARS-CoV-2 disease. Practical recommendations, which can be drawn from the literature, are given.

Mots-clés
  • SARS-CoV-2
  • COVID-19
  • Immunity
  • Cannabinoids
  • Endocannabinoid system
Citation (format ISO)
EL BIALI, Myriam et al. Cannabinoids and COVID-19. In: Medical Cannabis and Cannabinoids, 2020, p. 1–5. doi: 10.1159/000510799
Fichiers principaux (1)
Article (Published version)
Identifiants
ISSN du journal2504-3889
194vues
86téléchargements

Informations techniques

Création24/08/2020 16:55:00
Première validation24/08/2020 16:55:00
Heure de mise à jour15/03/2023 22:53:19
Changement de statut15/03/2023 22:53:18
Dernière indexation12/02/2024 13:19:47
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack